|
Study proves BioCote® reduces levels of bacteria
 BioCote Ltd, global leader of branded antimicrobial technology, will be exhibiting at Medica on the ABHI UK Pavilion in Hall 16 on stand 16F20-6.
BioCote Ltd will be promoting the results from the first ever study to look at how silver antimicrobial products can reduce levels of bacteria in an NHS hospital environment.
The environmental trial compared two out-patient units at the Heart of England NHS Foundation Trust. One facility was equipped with BioCote® protected furniture and equipment and one contained standard, untreated items. The products tested in the trials included blinds, tiles, door handles, sack holders and light switches.
The results showed a 95.8 per cent reduction in bacteria in the environment that contained BioCote® protected products, compared to the control facility, with no BioCote® present. The trial proves that using BioCote® protected products in a hospital environment can result in a reduction in bacteria, leading to a more hygienic and safer environment for patients. Fewer bacteria can reduce the risks of cross-contamination and consequently the risks of patients being infected with “superbugs” such as MRSA.
Matthew Harte, Managing Director, comments: “Despite regular cleaning, it is impossible to keep surfaces clean every minute of every day. BioCote works 24 hours a day, to reduce the levels of bacteria, mould and fungi on surfaces, in between cleaning.”
For more information
Tel: 01902 824450
E-mail:
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Web: www.biocote.com |
